Arbutus Biopharma Corp (ABUS)

SG&A Expenses

$16.48M

TTM · Period ending: · USD

ABUS logo

ABUS SG&A Expenses

Latest reported$16.48M
ABUS TTM SG&A Expenses ($3.71M → $16.48M)
High-resolution chart · PNG

ABUS sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arbutus Biopharma Corp SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
16,478,000
15,939,000
15,893,000
20,625,000
22,129,000
26,348,000
25,828,000
22,497,000
23,802,000
22,235,000
22,475,000
21,623,000
19,274,000
18,494,000
17,834,000
18,182,000
18,872,000
18,150,000
17,136,000
16,200,000
16,082,000
15,170,000
14,845,000
13,061,000
12,245,000
16,868,000
17,727,000
21,777,000
21,159,000
16,745,000
16,002,000
13,618,000
14,646,000
15,470,000
16,129,000
17,319,000
17,380,000
36,547,000
39,438,000
43,059,000
47,045,000
30,979,000
26,476,000
21,204,000
15,262,000
9,349,000
8,683,000
8,450,219
7,645,001
6,688,622
5,542,074
23,763,717
24,333,649
25,866,475
26,788,755
7,714,547
7,349,736
6,632,539
6,392,961
5,727,661
6,000,115
5,379,371
4,769,548
4,576,872
4,010,892
3,949,734
3,743,145
2,835,464
3,007,957
3,812,802
3,705,272
4,524,922
4,292,802
4,085,485
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.